SEER Revenue and Competitors

Claim your profile

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • SEER's estimated annual revenue is currently $12.2M per year.(i)
  • SEER's estimated revenue per employee is $150,370

Employee Data

  • SEER has 81 Employees.(i)
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$261.7M79219%$10.8MN/A
#2
$41400M2069906%$157.8M$234.2B
#3
$3.8M32N/AN/AN/A
#4
$114.9M615-1%$223.2M$1.6B
#5
$13.8M907%$30.3MN/A
#6
$85M451N/AN/AN/A
#7
$14.6M97-15%N/AN/A
#8
$116.9M607N/AN/AN/A
#9
$255.2M120912%N/AN/A
#10
$4.1M34N/AN/AN/A
#11
$26.8M16410%£14.4MN/A
#12
$12M80N/AN/AN/A
#13
$5.3M44N/AN/AN/A
#14
$116M61510%N/AN/A
#15
$55.5M294N/AN/AN/A
#16
$5.5M45N/AN/AN/A
#17
N/A4N/AN/AN/A
#18
$149.6M767-5%$10MN/A
#19
$339M969N/AN/AN/A
#20
$8.5M67-37%$45.1MN/A
Add Company

keywords:N/A

N/A

Total Funding

81

Number of Employees

$12.2M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

SEER News

2022-04-20 - Insider Selling: Seer, Inc. (NASDAQ:SEER) COO Sells 52042 ...

Insider Selling: Seer, Inc. (NASDAQ:SEER) COO Sells 52,042 Shares of Stock. Posted by admin on Apr 22nd, 2022. Share on Twitter Share on Facebook Share on...

2022-04-20 - Insider Selling: Seer, Inc. (NASDAQ:SEER) COO Sells 52042 ...

Insider Selling: Seer, Inc. (NASDAQ:SEER) COO Sells 52,042 Shares of Stock. Posted by admin on Apr 22nd, 2022. Share on Twitter Share on Facebook Share on...

2022-04-20 - Insider Selling: Seer, Inc. (NASDAQ:SEER) COO Sells 52042 ...

Insider Selling: Seer, Inc. (NASDAQ:SEER) COO Sells 52,042 Shares of Stock. Posted by admin on Apr 22nd, 2022. Share on Twitter Share on Facebook Share on...

2022-04-19 - Expanded SEER Registries Dataset Shows Improved Survival for DecisionDx®-Melanoma Tested Patients Compared to Untested Patients

Expanded SEER Registries Dataset Shows Improved Survival for DecisionDx®-Melanoma Tested Patients Compared to Untested Patients · FRIENDSWOOD,...

2022-04-19 - Expanded SEER Registries Dataset Shows Improved Survival for DecisionDx®-Melanoma Tested Patients Compared to Untested Patients

Expanded SEER Registries Dataset Shows Improved Survival for DecisionDx®-Melanoma Tested Patients Compared to Untested Patients · FRIENDSWOOD,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$11.2M8222%$94.4M
#2
$14.7M8311%N/A
#3
$22.2M83-2%N/A
#4
$7.5M8450%N/A
#5
$15M84-62%N/A